University of York uses G:BOX Imaging System
News Jun 01, 2010
Syngene announces a G:BOX chemiluminescence imaging system is being used at the University of York as a fast, affordable method to determine expression of a wide range of proteins on chemiluminescent Western blots.
Scientists in the Technology Facility at the University of York are using a G:BOX chemiluminescence imaging system to image Western blots stained with alkaline phosphatase to screen new constructs for protein expression. This imaging ensures researchers in the facility can demonstrate that recombinant clones are expressing the correct proteins and deliver them to other scientists for use in their studies.
Dr Jared Cartwright, a Laboratory Head in the Technology Facility explained: “We run a protein production service for researchers at York and other universities and to make this facility cost-efficient we have to use detection techniques with our Western blots which will identify the target proteins. Additionally, we have to analyse the results rapidly so using autoradiography was becoming too time consuming, expensive and presented issues with the incorporation of data in reports and publications.”
Dr Cartwright added: “To overcome these problems we assessed three different CCD imaging systems to determine which would best suit our range of applications. We found the G:BOX’s image capture and analysis software were simple to use and the quality of data was more precise than we previously obtained with autoradiography. As a result, we installed the system in 2008 and have been happy with its performance ever since.”
The spatial and temporal dynamics of proteins or organelles plays a crucial role in controlling various cellular processes and in development of diseases. However, acute control of activity at distinct locations within a cell cannot be achieved. A new chemo-optogenetic method enables tunable, reversible, and rapid control of activity at multiple subcellular compartments within a living cell.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE